Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Antimicrobial Resistance in Hospitals
- 1 April 1997
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 18 (4), 275-291
- https://doi.org/10.2307/30141215
Abstract
Antimicrobial resistance results in increased morbidity, mortality, and costs of health care. Prevention of the emergence of resistance and the dissemination of resistant microorganisms will reduce these adverse effects and their attendant costs. Appropriate antimicrobial stewardship that includes optimal selection, dose, and duration of treatment, as well as control of antibiotic use, will prevent or slow the emergence of resistance among microorganisms. A comprehensively applied infection control program will interdict the dissemination of resistant strains.Keywords
This publication has 63 references indexed in Scilit:
- Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadershipPublished by American Medical Association (AMA) ,1996
- Detection and surveillance of antimicrobial resistanceTrends in Microbiology, 1994
- Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratoryDiagnostic Microbiology and Infectious Disease, 1993
- Colonization and Cross-Colonization of Nursing Home Patients with Trimethoprim-Resistant Gram-Negative BacilliClinical Infectious Diseases, 1993
- Influence of amikacin as the primary aminoglycoside on bacterial isolates in the intensive care unitCritical Care Medicine, 1990
- Implementing and evaluating a system of generic infection precautions: Body substance isolationAmerican Journal of Infection Control, 1990
- Effect of an educational intervention on oral cephalosporin use in primary careArchives of Internal Medicine, 1987
- Clinical and microbiologic consequences of amikacin use during a 42-month periodArchives of Internal Medicine, 1986
- Effect of formulary restriction of cefotaxime usageArchives of Internal Medicine, 1985
- Long-term amikacin use. Effects on aminoglycoside susceptibility patterns of gram-negative bacilliJAMA, 1982